Variables | Without CV complications (N = 455) | With CV complications (N = 470) | P value |
---|---|---|---|
Age (year) | 69.19 (59.20–79.24) | 76.55 (67.74–82.83) | < 0.001 |
Gender (male), n (%) | 303 (66.59%) | 290 (61.70%) | 0.121 |
Insurance types | |||
Insurance-Government, n (%) | 6 (1.32%) | 4 (0.85%) | < 0.001 |
Insurance-Medicaid, n (%) | 37 (8.13%) | 25 (5.32%) | |
Insurance-Medicare, n (%) | 297 (65.27%) | 369 (78.51%) | |
Insurance-Private, n (%) | 112 (24.62%) | 72 (15.32%) | |
Insurance-Self Pay, n (%) | 3 (0.66%) | 0 (0.00%) | |
Ethnicity | |||
Ethnicity-White, n (%) | 329 (72.31%) | 354 (75.32%) | 0.601 |
Ethnicity-Black, n (%) | 55 (12.09%) | 50 (10.64%) | |
Ethnicity-Asian, n (%) | 10 (2.20%) | 13 (2.77%) | |
Ethnicity-Other, n (%) | 61 (13.41%) | 53 (11.28%) | |
Concomitant diseases | |||
Hypertension, n (%) | 36 (7.91%) | 35 (7.45%) | 0.790 |
Diabetes, n (%) | 27 (5.93%) | 42 (8.94%) | 0.082 |
Malignant tumor, n (%) | 53 (11.65%) | 23 (4.89%) | < 0.001 |
CV complications | |||
HF, n (%) | – | 427 (90.85%) | – |
MI, n (%) | – | 39 (8.30%) | – |
Stroke, n (%) | – | 40 (8.51%) | – |
Medication during ICU | |||
Albumin, n (%) | 98 (21.54%) | 85 (18.09%) | 0.187 |
βRB, n (%) | 259 (56.92%) | 319 (67.87%) | < 0.001 |
Statins, n (%) | 92 (20.22%) | 143 (30.43%) | < 0.001 |
Heparin, n (%) | 265 (58.24%) | 265 (56.38%) | 0.568 |
Death during ICU, n (%) | 88 (19.34%) | 109 (23.19%) | 0.153 |
1-year mortality after ICU, n (%) | 180 (39.56%) | 226 (48.09%) | 0.009 |